Knoll Capital Management, LLC Applied Therapeutics Inc. Transaction History
Knoll Capital Management, LLC
- $147 Million
- Q2 2025
A detailed history of Knoll Capital Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 7,799,687 shares of APLT stock, worth $3.43 Million. This represents 1.64% of its overall portfolio holdings.
Number of Shares
7,799,687
Previous 7,799,687
-0.0%
Holding current value
$3.43 Million
Previous $3.82 Million
36.74%
% of portfolio
1.64%
Previous 2.55%
Shares
15 transactions
Others Institutions Holding APLT
# of Institutions
82Shares Held
89.6MCall Options Held
165KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$8.22 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$5.06 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.97 Million4.26% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$2.08 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $21.1M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...